Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rehabilitation Centers | 6 | 2017 | 249 | 0.980 |
Why?
|
| Phenol | 2 | 2013 | 45 | 0.860 |
Why?
|
| Patient Transfer | 3 | 2017 | 792 | 0.830 |
Why?
|
| Rehabilitation | 3 | 2019 | 129 | 0.790 |
Why?
|
| Cancer Care Facilities | 5 | 2017 | 427 | 0.780 |
Why?
|
| Inpatients | 7 | 2018 | 2566 | 0.710 |
Why?
|
| Disability Evaluation | 4 | 2018 | 1835 | 0.650 |
Why?
|
| Pelvic Exenteration | 1 | 2017 | 22 | 0.590 |
Why?
|
| Insurance, Disability | 1 | 2017 | 26 | 0.570 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2016 | 24 | 0.540 |
Why?
|
| Stiff-Person Syndrome | 1 | 2016 | 31 | 0.530 |
Why?
|
| Nerve Block | 2 | 2013 | 716 | 0.520 |
Why?
|
| Neoplasms | 15 | 2019 | 22371 | 0.490 |
Why?
|
| Muscle Spasticity | 2 | 2013 | 159 | 0.480 |
Why?
|
| Paraneoplastic Cerebellar Degeneration | 1 | 2014 | 13 | 0.470 |
Why?
|
| Insurance Carriers | 1 | 2016 | 159 | 0.450 |
Why?
|
| Knee | 1 | 2015 | 277 | 0.430 |
Why?
|
| Terminal Care | 2 | 2015 | 1770 | 0.400 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 191 | 0.390 |
Why?
|
| Fatigue | 2 | 2016 | 1557 | 0.370 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1179 | 0.340 |
Why?
|
| Palliative Care | 4 | 2018 | 3643 | 0.330 |
Why?
|
| Pain | 2 | 2015 | 5100 | 0.320 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2012 | 238 | 0.320 |
Why?
|
| Leukemia | 2 | 2013 | 1519 | 0.290 |
Why?
|
| Lymphoma | 2 | 2013 | 1898 | 0.290 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 1444 | 0.280 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 1596 | 0.270 |
Why?
|
| Hospitalization | 7 | 2018 | 10840 | 0.260 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1886 | 0.260 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1907 | 0.260 |
Why?
|
| Hemorrhage | 1 | 2018 | 3467 | 0.250 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 1424 | 0.250 |
Why?
|
| Astrocytoma | 1 | 2010 | 774 | 0.250 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2709 | 0.230 |
Why?
|
| Carcinoma | 1 | 2014 | 2332 | 0.210 |
Why?
|
| Retrospective Studies | 15 | 2018 | 81762 | 0.190 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 5196 | 0.190 |
Why?
|
| Physical Therapy Modalities | 2 | 2015 | 533 | 0.180 |
Why?
|
| Primary Health Care | 2 | 2017 | 4746 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7454 | 0.170 |
Why?
|
| Fellowships and Scholarships | 2 | 2019 | 1135 | 0.170 |
Why?
|
| Platelet Count | 2 | 2013 | 787 | 0.170 |
Why?
|
| Length of Stay | 6 | 2018 | 6498 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2013 | 3288 | 0.160 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3800 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9419 | 0.160 |
Why?
|
| Middle Aged | 17 | 2018 | 223492 | 0.150 |
Why?
|
| Antifungal Agents | 2 | 2013 | 761 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 4916 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 300 | 0.140 |
Why?
|
| Activities of Daily Living | 3 | 2018 | 2430 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5717 | 0.140 |
Why?
|
| Brain Neoplasms | 3 | 2016 | 9118 | 0.130 |
Why?
|
| Consumer Health Information | 1 | 2018 | 215 | 0.130 |
Why?
|
| Female | 20 | 2019 | 397192 | 0.130 |
Why?
|
| Humans | 31 | 2019 | 768166 | 0.120 |
Why?
|
| Patient Selection | 2 | 2017 | 4260 | 0.120 |
Why?
|
| Speech Therapy | 1 | 2014 | 58 | 0.120 |
Why?
|
| Subacute Care | 1 | 2017 | 187 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7951 | 0.110 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
| Occupational Therapy | 1 | 2014 | 141 | 0.100 |
Why?
|
| Quality of Life | 5 | 2017 | 13490 | 0.100 |
Why?
|
| Blast Crisis | 1 | 2013 | 102 | 0.100 |
Why?
|
| Aged | 10 | 2017 | 171504 | 0.100 |
Why?
|
| Male | 17 | 2019 | 364719 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 556 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 536 | 0.100 |
Why?
|
| Hospice Care | 1 | 2018 | 678 | 0.100 |
Why?
|
| Hospital Units | 1 | 2012 | 142 | 0.090 |
Why?
|
| Hemipelvectomy | 1 | 2011 | 8 | 0.090 |
Why?
|
| Neuromuscular Agents | 1 | 2012 | 148 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 631 | 0.090 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 123 | 0.090 |
Why?
|
| Antiviral Agents | 2 | 2013 | 3073 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 957 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2017 | 939 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13586 | 0.080 |
Why?
|
| Injections | 1 | 2012 | 840 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2017 | 65371 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 59629 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 250 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2013 | 1609 | 0.080 |
Why?
|
| Logistic Models | 2 | 2013 | 13290 | 0.070 |
Why?
|
| Survivors | 2 | 2015 | 2381 | 0.070 |
Why?
|
| Incidence | 2 | 2017 | 21538 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 21206 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1918 | 0.070 |
Why?
|
| Internet | 1 | 2018 | 3110 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2017 | 24315 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3706 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3782 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3929 | 0.060 |
Why?
|
| Caregivers | 1 | 2017 | 2302 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1883 | 0.060 |
Why?
|
| Adult | 8 | 2018 | 223646 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3620 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10101 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1480 | 0.050 |
Why?
|
| Movement | 1 | 2010 | 1490 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2016 | 3479 | 0.050 |
Why?
|
| Young Adult | 3 | 2013 | 60066 | 0.050 |
Why?
|
| Recovery of Function | 3 | 2018 | 2981 | 0.050 |
Why?
|
| Glioma | 1 | 2016 | 3503 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2015 | 3464 | 0.040 |
Why?
|
| Prognosis | 2 | 2017 | 30010 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5349 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5107 | 0.040 |
Why?
|
| United States | 5 | 2019 | 73039 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2017 | 41754 | 0.030 |
Why?
|
| Specialization | 1 | 2018 | 779 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7477 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 40218 | 0.030 |
Why?
|
| Cognition | 1 | 2010 | 7073 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39348 | 0.020 |
Why?
|
| Self Care | 1 | 2017 | 799 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2015 | 905 | 0.020 |
Why?
|
| Child | 2 | 2011 | 80917 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 89169 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3436 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2663 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2019 | 4858 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12840 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3583 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 54926 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74944 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15832 | 0.000 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_